Oruka Therapeutics, Inc.
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 17, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 17, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 17, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 17, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 17, 2026 |
| S-8 | REGISTRATION STATEMENT | Mar 12, 2026 |
| 10-K | ANNUAL REPORT | Mar 12, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Mar 2, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | Feb 17, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Kiselak Tomas | — | Award / Grant | 333,340 @ $15.00 | 1,131,954 | Sep 17, 2025 |
| VHCP Management III, LLC | — | Purchase | 9,593 @ $10.95 | 4,035,713 | Feb 10, 2025 |
| Kiselak Tomas | — | Award / Grant | 275,000 @ $23.00 | 638,614 | Sep 11, 2024 |
| Janus Henderson Biotech Innovation Master Fund Ltd | — | Purchase | 428 @ $2.98 | 2,117,213 | Aug 16, 2024 |
| JANUS HENDERSON GROUP PLC | — | Purchase | 165,000 @ $3.20 | 2,056,312 | Jul 25, 2024 |
| Janus Henderson Biotech Innovation Master Fund Ltd | — | Purchase | 17,600 @ $3.54 | 1,724,395 | Jul 3, 2024 |
| Keuer Thomas A | Chief Operating Officer | Award / Grant | 40,000 | 40,730 | Dec 8, 2022 |
| Dekker C. Jeffrey | Chief Financial Officer | Award / Grant | 40,000 | 40,000 | Dec 8, 2022 |
| Ma-Weaver Jacob | — | Purchase | 64,851 @ $2.32 | 2,580,452 | May 23, 2022 |
| Ma-Weaver Jacob | — | Purchase | 13,072 @ $2.30 | 2,495,189 | May 19, 2022 |